Troxerutin suppresses the stemness of osteosarcoma via the CD155/SRC/β-catenin signaling axis

Troxerutin suppresses the stemness of osteosarcoma via the CD155/SRC/β-catenin signaling axis

Abstract Background Osteosarcoma is the most prevalent primary malignant bone tumor affecting pediatric and adolescent individuals. However, despite the passage of three decades, there has been no notable enhancement in the overall survival rate of patients with osteosarcoma. In recent years, CD155...

Full description

Saved in:
Bibliographic Details
Main Authors: Junkai Chen, Hongbo Li, Qinglin Jin, Xiaoguang Li, Yiwen Zhang, Jingnan Shen, Gang Huang, Junqiang Yin, Changye Zou, Xinyu Li, Xin He, Xianbiao Xie, Tiao Lin
Format: Article
Language:English
Published: BMC 2025-04-01
Series:Cellular & Molecular Biology Letters
Subjects:
CD155
Osteosarcoma
β-catenin
Stemness
Troxerutin
Online Access:https://doi.org/10.1186/s11658-025-00724-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s11658-025-00724-8

Similar Items